GlassScriptPhysician profile
Blake J Evans
NPI 1093971467
$6,416.10
in general payments reported to CMS, 2019-2025
47 companies · $1,480 in 2025
The $1,480 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,198 · 2020: $282 · 2021: $285 · 2022: $413 · 2023: $1,442 · 2024: $1,317 · 2025: $1,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,208 · Travel and Lodging: $29.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,208.38 |
| Travel and Lodging | $29.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $918.80 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml, Rezum Generator |
| Myriad Genetic Laboratories, INC. | $834.81 | 2021-2025 | Prolaris, Myrisk |
| Janssen Biotech, INC. | $359.87 | 2019-2025 | Erleada |
| Teleflex LLC | $296.49 | 2022-2025 | Urolift |
| Procept Biorobotics Corporation | $292.73 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Astellas Pharma US INC | $270.80 | 2019-2024 | Myrbetriq, Xtandi |
| Emd Serono, INC. | $208.38 | 2019-2020 | |
| Axonics, INC. | $202.69 | 2020-2024 | Axonics |
| Pfizer INC. | $179.71 | 2019-2025 | |
| Abbvie INC. | $176.51 | 2019-2025 | |
| Coloplast Corp | $175.50 | 2022-2025 | Speedicath |
| Endo USA, INC. | $172.65 | 2024-2025 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $168.29 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $165.36 | 2023-2025 | Orgovyx, Gemtesa |
| Verity Pharmaceuticals INC. | $163.67 | 2023-2025 | Trelstar, Tlando |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $150.12 | 2021-2025 | |
| Tolmar, INC. | $140.52 | 2023-2025 | Jatenzo, Eligard |
| Novartis Pharmaceuticals Corporation | $129.56 | 2022-2025 | |
| Endo Pharmaceuticals INC. | $127.38 | 2019-2023 | Xiaflex |
| Convatec INC. | $114.81 | 2021-2025 | |
| Accord Healthcare, INC. | $109.36 | 2023-2025 | |
| Medtronic, INC. | $84.78 | 2023-2025 | Intellis Adaptivestim, Interstim |
| Blue Earth Diagnostics | $79.35 | 2019-2022 | |
| Telix Pharmaceuticals | $75.16 | 2024-2025 | Illuccix |
| C. R. Bard, INC. & Subsidiaries | $73.01 | 2019-2022 | |
| Antares Pharma, INC. | $72.87 | 2019-2025 | Xyosted |
| Urogen Pharma, INC. | $69.74 | 2023-2025 | Jelmyto |
| Valencia Technologies Corporation | $53.97 | 2025 | Ecoin Device Kit |
| Kowa Pharmaceuticals America, INC. | $52.01 | 2023 | Seglentis |
| Astrazeneca Pharmaceuticals LP | $49.08 | 2022-2023 | Lynparza |
| Allergan, INC. | $42.03 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $39.23 | 2020-2022 | |
| Bluewind Medical | $35.87 | 2025 | Revi |
| Ferring Pharmaceuticals INC. | $35.72 | 2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $34.85 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Dendreon Pharmaceuticals LLC | $31.50 | 2019 | |
| Abbott Laboratories | $29.57 | 2025 | Proclaim |
| Biotissue Holdings INC. | $27.25 | 2024 | |
| Progenics Pharmaceuticals, INC. | $25.38 | 2025 | |
| Becton, Dickinson and Company | $24.10 | 2024 | Bard Urinary Drainage Bag |
| Urovant Sciences INC | $21.39 | 2022 | |
| 180 Medical, INC. | $19.04 | 2020 | |
| Cardinal Health 414 LLC | $18.65 | 2023 | |
| Immunitybio, INC. | $18.34 | 2024 | |
| Calyxo, INC. | $16.67 | 2025 | Cvac Aspiration System |
| Travere Therapeutics, INC. | $16.44 | 2019 | |
| Medtronic USA, INC. | $12.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.